Literature DB >> 22092935

Presence of functional, autoreactive human milk-specific IgE in infants with cow's milk allergy.

K M Järvinen1, L Geller, R Bencharitiwong, H A Sampson.   

Abstract

BACKGROUND: Occasionally, exclusively breastfed infants with cow's milk allergy (CMA) remain symptomatic despite strict maternal milk avoidance.
OBJECTIVE: To determine whether or not persistence of symptoms could be due to sensitization against endogenous human milk proteins with a high degree of similarity to bovine allergens.
METHODS: Ten peptides representing known bovine milk IgE-binding epitopes [α-lactalbumin (ALA), β- and κ-casein] and the corresponding, highly homologous human milk peptides were labelled with sera from 15 breastfed infants with CMA, aged 3 weeks to 12 months, and peptide (epitope)-specific IgE antibodies were assessed. Nine of the 15 breastfed infants became asymptomatic during strict maternal avoidance of milk and other major food allergens; six infants remained symptomatic until weaned. Ten older children, aged 5-15 years, with CMA were also assessed. The functional capacity of specific IgE antibodies was assessed by measuring β-hexosaminidase release from rat basophilic leukaemia cells passively sensitized and stimulated with human and bovine ALA.
RESULTS: A minimum of one human milk peptide was recognized by IgE antibodies from 9 of 15 (60%) milk-allergic infants, and the majority of older children with CMA. Genuine sensitization to human milk peptides in the absence of IgE to bovine milk was occasionally seen. There was a trend towards specific IgE being detected to more human milk peptides in those infants who did not respond to the maternal milk elimination diet than in those who did (P = 0.099). Functional IgE antibody to human ALA was only detected in infants not responding to the maternal diet. CONCLUSIONS AND CLINICAL RELEVANCE: Endogenous human milk epitopes are recognized by specific IgE from the majority of infants and children with CMA. Such autoreactive, human milk-specific IgE antibodies appear to have functional properties in vitro. Their role in provoking allergic symptoms in infants exclusively breastfed by mothers strictly avoiding dietary milk remains unclear.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092935      PMCID: PMC3780604          DOI: 10.1111/j.1365-2222.2011.03864.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  27 in total

1.  Detection of specific IgE to human milk proteins in sera of atopic infants.

Authors:  A Cantisani; M G Giuffrida; C Fabris; E Bertino; A Coscia; R Oggero; G Monti; P Stroppiana; A Conti
Journal:  FEBS Lett       Date:  1997-08-04       Impact factor: 4.124

2.  The cradle of IgE autoreactivity in atopic eczema lies in early infancy.

Authors:  Nadine Mothes; Bodo Niggemann; Claudia Jenneck; Tobias Hagemann; Stephan Weidinger; Thomas Bieber; Rudolf Valenta; Natalija Novak
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

3.  Characterization of the unfolded state of bovine alpha-lactalbumin and comparison with unfolded states of homologous proteins.

Authors:  Julia Wirmer; Holger Berk; Raffaella Ugolini; Christina Redfield; Harald Schwalbe
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

4.  Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism.

Authors:  Jens Derbinski; Sheena Pinto; Stefanie Rösch; Klaus Hexel; Bruno Kyewski
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-07       Impact factor: 11.205

5.  Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: A prospective study of 6209 infants.

Authors:  K M Saarinen; K Juntunen-Backman; A L Järvenpää; P Kuitunen; L Lope; M Renlund; M Siivola; E Savilahti
Journal:  J Allergy Clin Immunol       Date:  1999-08       Impact factor: 10.793

6.  Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity.

Authors:  Karl J Aichberger; Irene Mittermann; Renate Reininger; Susanne Seiberler; Ines Swoboda; Susanne Spitzauer; Tamara Kopp; Georg Stingl; Wolfgang R Sperr; Peter Valent; Andreas Repa; Barbara Bohle; Dietrich Kraft; Rudolf Valenta
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

Review 7.  Guidelines for the diagnosis and management of cow's milk protein allergy in infants.

Authors:  Yvan Vandenplas; Sibylle Koletzko; Erika Isolauri; David Hill; Arnold P Oranje; Martin Brueton; Annamaria Staiano; Christophe Dupont
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

8.  Sensitization to human milk.

Authors:  U Schulmeister; I Swoboda; S Quirce; B de la Hoz; M Ollert; G Pauli; R Valenta; S Spitzauer
Journal:  Clin Exp Allergy       Date:  2007-10-29       Impact factor: 5.018

Review 9.  Food allergy: recent advances in pathophysiology and treatment.

Authors:  Scott H Sicherer; Hugh A Sampson
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

10.  Identification of amino acids critical for IgE-binding to sequential epitopes of bovine kappa-casein and the similarity of these epitopes to the corresponding human kappa-casein sequence.

Authors:  N Han; K M Järvinen; R R Cocco; P J Busse; H A Sampson; K Beyer
Journal:  Allergy       Date:  2008-02       Impact factor: 13.146

View more
  2 in total

Review 1.  Mother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child Transmission.

Authors:  Florent Percher; Patricia Jeannin; Sandra Martin-Latil; Antoine Gessain; Philippe V Afonso; Aurore Vidy-Roche; Pierre-Emmanuel Ceccaldi
Journal:  Viruses       Date:  2016-02-03       Impact factor: 5.048

Review 2.  Influences of Maternal Factors Over Offspring Allergies and the Application for Food Allergy.

Authors:  Takashi Fujimura; Shelly Zing Chin Lum; Yuka Nagata; Seiji Kawamoto; Michiko K Oyoshi
Journal:  Front Immunol       Date:  2019-08-23       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.